Biblio

Export 307 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Keyword is T  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Y
R. Yu, Deochand, C., Krotow, A., Leão, R., Tong, M., Agarwal, A. R., Cadenas, E., and de la Monte, S. M., Tobacco Smoke-Induced Brain White Matter Myelin Dysfunction: Potential Co-Factor Role of Smoking in Neurodegeneration., J Alzheimers Dis, vol. 50, no. 1, pp. 133-48, 2016.
R. Yu, Deochand, C., Krotow, A., Leão, R., Tong, M., Agarwal, A. R., Cadenas, E., and de la Monte, S. M., Tobacco Smoke-Induced Brain White Matter Myelin Dysfunction: Potential Co-Factor Role of Smoking in Neurodegeneration., J Alzheimers Dis, vol. 50, no. 1, pp. 133-48, 2016.
L. Yu, Liu, Y., Jin, Y., Cao, X., Chen, J., Jin, J., Gu, Y., Bao, X., Ren, Z., Xu, Y., and Zhu, X., Lentivirus-Mediated HDAC3 Inhibition Attenuates Oxidative Stress in APPswe/PS1dE9 Mice., J Alzheimers Dis, vol. 61, no. 4, pp. 1411-1424, 2018.
X. Yin, Jiang, X., Wang, J., Qian, S., Liu, F., and Qian, W., SIRT1 Deacetylates SC35 and Suppresses Its Function in Tau Exon 10 Inclusion., J Alzheimers Dis, vol. 61, no. 2, pp. 561-570, 2018.
X. Yin, Jiang, X., Wang, J., Qian, S., Liu, F., and Qian, W., SIRT1 Deacetylates SC35 and Suppresses Its Function in Tau Exon 10 Inclusion., J Alzheimers Dis, vol. 61, no. 2, pp. 561-570, 2018.
C. -cui Yang, Kuai, X. -xian, bin Gao, W. -, Yu, J. -chun, Wang, Q., Li, L., and Zhang, L., Morroniside-Induced PP2A Activation Antagonizes Tau Hyperphosphorylation in a Cellular Model of Neurodegeneration., J Alzheimers Dis, vol. 51, no. 1, pp. 33-44, 2016.
C. -cui Yang, Kuai, X. -xian, bin Gao, W. -, Yu, J. -chun, Wang, Q., Li, L., and Zhang, L., Morroniside-Induced PP2A Activation Antagonizes Tau Hyperphosphorylation in a Cellular Model of Neurodegeneration., J Alzheimers Dis, vol. 51, no. 1, pp. 33-44, 2016.
C. - C. Yang, Chiu, M. - J., Chen, T. - F., Chang, H. - L., Liu, B. - H., and Yang, S. - Y., Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 4, pp. 1323-1332, 2018.
C. -cui Yang, Kuai, X. -xian, bin Gao, W. -, Yu, J. -chun, Wang, Q., Li, L., and Zhang, L., Morroniside-Induced PP2A Activation Antagonizes Tau Hyperphosphorylation in a Cellular Model of Neurodegeneration., J Alzheimers Dis, vol. 51, no. 1, pp. 33-44, 2016.
Y. Yan, Wu, X., Wang, X., Geng, Z., Wang, L., Xiao, G., Wu, Y., Zhou, S., Liao, R., Wei, L., Tian, Y., and Wang, K., The Retinal Vessel Density Can Reflect Cognitive Function in Patients with Alzheimer's Disease: Evidence from Optical Coherence Tomography Angiography., J Alzheimers Dis, vol. 79, no. 3, pp. 1307-1316, 2021.
W
L. Wu, Liu, J., Feng, X., Dong, J., Qin, W., Liu, Y., Wang, J., Lu, J., Chen, K., Wang, Y., and Jia, J., 11C-CFT-PET in Presymptomatic FTDP-17: A Potential Biomarker Predicting Onset., J Alzheimers Dis, vol. 61, no. 2, pp. 613-618, 2018.
W. Wruck, Schröter, F., and Adjaye, J., Meta-Analysis of Transcriptome Data Related to Hippocampus Biopsies and iPSC-Derived Neuronal Cells from Alzheimer's Disease Patients Reveals an Association with FOXA1 and FOXA2 Gene Regulatory Networks., J Alzheimers Dis, vol. 50, no. 4, pp. 1065-82, 2016.
A. L. Wiseman, Briggs, C. A., Peritt, A., Kapecki, N., Peterson, D. A., Shim, S. S., and Stutzmann, G. E., Lithium Provides Broad Therapeutic Benefits in an Alzheimer's Disease Mouse Model., J Alzheimers Dis, vol. 91, no. 1, pp. 273-290, 2023.
A. Winkler, Weimar, C., Jöckel, K. - H., Erbel, R., Dragano, N., Broecker-Preuss, M., Moebus, S., Führer-Sakel, D., and Dlugaj, M., Thyroid-Stimulating Hormone and Mild Cognitive Impairment: Results of the Heinz Nixdorf Recall Study., J Alzheimers Dis, vol. 49, no. 3, pp. 797-807, 2016.
G. K. Wilcock, Gauthier, S., Frisoni, G. B., Jia, J., Hardlund, J. H., Moebius, H. J., Bentham, P., Kook, K. A., Schelter, B. O., Wischik, D. J., Davis, C. S., Staff, R. T., Vuksanovic, V., Ahearn, T., Bracoud, L., Shamsi, K., Marek, K., Seibyl, J., Riedel, G., Storey, J. M. D., Harrington, C. R., and Wischik, C. M., Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial., J Alzheimers Dis, vol. 61, no. 1, pp. 435-457, 2018.
M. T. White, Shaw, L. M., and Xie, S. X., Evaluation of Cerebrospinal Fluid Assay Variability in Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 2, pp. 463-70, 2016.
W. Wharton, Goldstein, F. C., Tansey, M. G., Brown, A. L., Tharwani, S. D., Verble, D. D., Cintron, A., and Kehoe, P. G., Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial., J Alzheimers Dis, vol. 61, no. 2, pp. 815-824, 2018.
R. Weissmann, Hüttenrauch, M., Kacprowski, T., Bouter, Y., Pradier, L., Bayer, T. A., Kuss, A. W., and Wirths, O., Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 2, pp. 397-409, 2016.
M. Wei, Zhao, B., Huo, K., Deng, Y., Shang, S., Liu, J., Li, Y., Ma, L., Jiang, Y., Dang, L., Chen, C., Wei, S., Zhang, J., Yang, H., Gao, F., and Qu, Q., Sleep Deprivation Induced Plasma Amyloid-β Transport Disturbance in Healthy Young Adults., J Alzheimers Dis, vol. 57, no. 3, pp. 899-906, 2017.

Pages